Teva Pharmaceutical Industries Ltd- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Teva Pharmaceutical Industries Ltd 公司

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Teva Pharmaceutical Industries Ltd简介



公司代码TEVA

公司名称Teva Pharmaceutical Industries Ltd

上市日期Feb 06, 2087

CEOFrancis (Richard D)

员工数量33892

证券类型Depository Receipt

年结日Feb 06

公司地址124 Dvora Hanevi'a St.

城市TEL AVIV-YAFO

上市交易所NASDAQ OMX NASDAQ Basic NYSE

国家Israel

邮编6944020

电话97239148213

网址https://www.tevapharm.com/

公司代码TEVA

上市日期Feb 06, 2087

CEOFrancis (Richard D)

Teva Pharmaceutical Industries Ltd公司高管



名称

名称/职务

职务

持股

持股变动

Prof. Varda Shalev

Independent Director

22.50K

+9632.00%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

+14280.00%

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

--

Mr. Chen Lichtenstein

Independent Director

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Amir Elstein

Independent Director

--

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

名称

名称/职务

职务

持股

持股变动

Prof. Varda Shalev

Independent Director

22.50K

+9632.00%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

+14280.00%

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

--

Mr. Chen Lichtenstein

Independent Director

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

收入明细

单位: USD更新时间: 1月6日周二

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Generic products

2.58B

57.54%

AUSTEDO

609.00M

13.59%

Anda

392.00M

8.75%

Other

274.00M

6.12%

AJOVY

169.00M

3.77%

其他

458.00M

10.22%

地区USD

名称

营收

占比

United States

2.48B

55.40%

Europe

1.24B

27.57%

International Markets

558.00M

12.46%

Other

205.00M

4.58%

业务

地区

业务USD

名称

营收

占比

Generic products

2.58B

57.54%

AUSTEDO

609.00M

13.59%

Anda

392.00M

8.75%

Other

274.00M

6.12%

AJOVY

169.00M

3.77%

其他

458.00M

10.22%

股东统计

更新时间: 1月11日周日

持股股东

股东类型

持股股东

占比

Harel Insurance Investments and Financial Services Ltd

3.91%

Phoenix Investment and Finances Ltd

3.57%

Menora Mivtachim Insurance Ltd.

3.38%

Migdal Insurance and Financial Holdings Ltd

3.25%

BlackRock Institutional Trust Company, N.A.

3.04%

其他

82.85%

持股股东

占比

Harel Insurance Investments and Financial Services Ltd

3.91%

Phoenix Investment and Finances Ltd

3.57%

Menora Mivtachim Insurance Ltd.

3.38%

Migdal Insurance and Financial Holdings Ltd

3.25%

BlackRock Institutional Trust Company, N.A.

3.04%

其他

82.85%

股东类型

持股股东

占比

Investment Advisor

23.09%

Investment Advisor/Hedge Fund

12.52%

Hedge Fund

10.41%

Insurance Company

6.65%

Research Firm

2.35%

Family Office

1.86%

Pension Fund

1.56%

Bank and Trust

0.85%

Sovereign Wealth Fund

0.24%

其他

40.48%

机构持股



更新时间: 1月1日周四

报告期

机构数

持股数

持股占比

持股变动

2025Q4

1165

666.08M

57.93%

-136.04M

2025Q3

1124

742.23M

64.70%

-84.92M

2025Q2

1100

749.18M

65.31%

-13.97M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Harel Insurance Investments and Financial Services Ltd

37.70M

3.29%

+4.31M

+12.90%

Sep 30, 2025

Phoenix Investment and Finances Ltd

41.30M

3.6%

+3.53M

+9.36%

Sep 30, 2025

Menora Mivtachim Insurance Ltd.

38.92M

3.39%

-18.47M

-32.19%

Sep 30, 2025

Migdal Insurance and Financial Holdings Ltd

32.58M

2.84%

+3.90M

+13.58%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

34.92M

3.04%

+1.03M

+3.04%

Sep 30, 2025

Clal Insurance Enterprises Holdings Ltd.

31.49M

2.74%

-876.00K

-2.71%

Sep 30, 2025

Lingotto Investment Management LLP

28.59M

2.49%

+431.87K

+1.53%

Sep 30, 2025

Rubric Capital Management LP

24.65M

2.15%

-1.35M

-5.19%

Sep 30, 2025

PointState Capital LP

20.71M

1.81%

--

Sep 30, 2025

Fidelity Management & Research Company LLC

20.19M

1.76%

-30.45M

-60.13%

Sep 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

iShares MSCI Israel ETF

7.76%

VanEck Israel ETF

7.5%

VanEck Pharmaceutical ETF

3.79%

First Trust WCM Developing World Equity ETF

3.16%

First Trust WCM International Equity ETF

2.64%

ARK Israel Innovative Technology ETF

1.81%

WealthTrust DBS Long Term Growth ETF

1.42%

WisdomTree International Multifactor Fund

0.77%

iShares Health Innovation Active ETF

0.69%

iShares MSCI Intl Value Factor ETF

0.46%

iShares MSCI Israel ETF

占比7.76%

VanEck Israel ETF

占比7.5%

VanEck Pharmaceutical ETF

占比3.79%

First Trust WCM Developing World Equity ETF

占比3.16%

First Trust WCM International Equity ETF

占比2.64%

ARK Israel Innovative Technology ETF

占比1.81%

WealthTrust DBS Long Term Growth ETF

占比1.42%

WisdomTree International Multifactor Fund

占比0.77%

iShares Health Innovation Active ETF

占比0.69%

iShares MSCI Intl Value Factor ETF

占比0.46%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据